Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
about
Replicon RNA Viral Vectors as VaccinesTechnological Microbiology: Development and ApplicationsNovel platform technology for modular mucosal vaccine that protects against streptococcus.Conveying a newly designed hydrophilic anti-human thymidylate synthase peptide to cisplatin resistant cancer cells: are pH-sensitive liposomes more effective than conventional ones?Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.A Recombinant Viral Hemorrhagic Septicemia Virus Genotype IVb Glycoprotein Produced in Cabbage Looper Larvae Trichoplusia ni Elicits Antibody Response and Protection in Muskellunge.Effect of Chitosan and Liposome Nanoparticles as Adjuvant Codelivery on the Immunoglobulin G Subclass Distribution in a Mouse Model.Vaccine Delivery Methods into the FutureLiposomal adjuvant development for leishmaniasis vaccines.Perspectives in allergen immunotherapy: 2017 and beyond.mRNA vaccines - a new era in vaccinology.PEGylation of cationic liposomes encapsulating soluble Leishmania antigens reduces the adjuvant efficacy of liposomes in murine model.The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigsCationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic PeptidesCo-delivery of a CD4 T cell helper epitope via covalent liposome attachment with a surface-arrayed B cell target antigen fosters higher affinity antibody responses
P2860
Q28076639-84E40A1E-17BC-4B39-979A-01356C4F562EQ30250972-9466088F-E59C-4AF0-A154-BF0C9ECAEAE3Q37504796-A553CFA8-3F99-46E1-B273-9D3911E30071Q38729056-4A1F4B58-4E17-4AEE-80BB-81C89364D76AQ38886698-DCC03D95-1EA2-4520-8F65-ED2F934E392CQ39174792-62110F93-20A6-4D8C-AEF8-B070C25A397AQ40217518-245266A6-6CAA-47FC-8F45-7580FFF2767EQ41056704-1DB18C49-B5CE-40E8-BA4F-0DF4300AEED8Q42434139-C8003959-249C-493F-9A90-9AF9DCB10D6FQ47153161-8BDA35DC-9E68-4E98-996E-4AD988D42EBEQ47700986-AB996AED-9AA8-4B59-A1EF-B5EFC40AB27EQ47736893-35BCD472-3336-43AF-9810-2F7190B2A77FQ48332907-FF21EA38-664E-4D29-AB2B-2F9594E30650Q50124824-9E74E1A4-5E50-4BFB-B35D-942FF485F6A8Q58698634-E8D32609-AFBC-4D17-AEB2-3EB739C672F6Q58745887-7893E3DB-0FF7-43BD-9DB4-1DE24D33461BQ58791545-8EC11B26-857C-486C-9EAC-EB582EF0BE29
P2860
Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@ast
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@en
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@nl
type
label
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@ast
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@en
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@nl
prefLabel
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@ast
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@en
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@nl
P2093
P2860
P3181
P1433
P1476
Liposome-Based Adjuvants for S ...... Antigens and Immunostimulators
@en
P2093
Camilla Foged
Karen Smith Korsholm
Signe Tandrup Schmidt
P2860
P3181
P356
10.3390/PHARMACEUTICS8010007
P407
P577
2016-03-10T00:00:00Z